Status:
UNKNOWN
Iatrogenic Withdrawal Symptoms in Severe Traumatic Brain Injury
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Iatrogenic Withdrawal Symptomes
Eligibility:
All Genders
18+ years
Brief Summary
Iatrogenic withdrawal symptomes has been associated with prolonged mechanical ventilation and the and the derived symptoms such as fever and agitation has been shown to cause significantly prolonged I...
Eligibility Criteria
Inclusion
- adult patients suffering from severe TBI and were mechanical ventilated and received continuous infusions of opioids, benzodiazepines and neuromuscular blocking agents for 72ours or more
Exclusion
- age \<18 years, patients who died before discharge, chronic alcohol abuse, regular use of heroin, cocaine and amphetamines, chronic use of opioids, patient that were primary admitted to other ICUs and patients that were moved to other ICUs with ongoing infusions.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
215 Patients enrolled
Trial Details
Trial ID
NCT04320927
Start Date
March 1 2020
End Date
August 1 2020
Last Update
April 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neuroanaesthesiology
Copenhagen, Capital Region, Denmark, 2200